US Stock MarketDetailed Quotes

CSTL Castle Biosciences

Watchlist
  • 30.440
  • -0.130-0.43%
Close Nov 27 16:00 ET
  • 30.440
  • 0.0000.00%
Post 16:02 ET
852.54MMarket Cap144.95P/E (TTM)

Castle Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
365.64%23.34M
733.86%24M
73.13%-6.84M
86.49%-5.63M
409.78%18.59M
195.94%5.01M
57.94%-3.79M
-18.71%-25.44M
-119.43%-41.66M
-115.75%-6M
Net income from continuing operations
132.86%2.27M
147.50%8.92M
91.32%-2.53M
14.41%-57.47M
87.49%-2.58M
65.90%-6.91M
-1,039.38%-18.78M
-18.60%-29.2M
-114.55%-67.14M
-220.65%-20.62M
Depreciation and amortization
11.56%3.54M
10.13%3.35M
15.49%3.34M
16.95%12.33M
13.48%3.22M
8.59%3.17M
15.68%3.04M
34.45%2.89M
209.45%10.54M
95.80%2.84M
Deferred tax
--5.25M
---1.54M
--0
88.12%-223K
-521.05%-236K
--0
--0
-89.43%13K
78.51%-1.88M
99.57%-38K
Other non cash items
76.06%125K
-4,900.00%-96K
-15.17%179K
103.50%635K
207.01%351K
1,875.00%71K
100.01%2K
-91.80%211K
---18.13M
---328K
Change In working capital
127.69%776K
1,149.67%1.91M
-61.38%-18.8M
-94,614.29%-6.63M
125.21%7.67M
-190.56%-2.8M
-95.71%153K
-15.61%-11.65M
99.83%-7K
-14.56%3.4M
-Change in receivables
26.67%-4.25M
6.59%-3.36M
2.76%-4.26M
-140.11%-14.93M
-113.15%-1.15M
-11,502.00%-5.8M
-23.84%-3.6M
-60.84%-4.38M
-34.27%-6.22M
-137.09%-540K
-Change in inventory
309.38%1.44M
77.01%-368K
155.00%297K
-135.83%-3.96M
-1,120.79%-2.17M
180.73%352K
-117.23%-1.6M
-64.13%-540K
-613.76%-1.68M
-150.14%-178K
-Change in prepaid assets
-31.90%-1.39M
-123.52%-191K
84.25%-103K
64.46%-435K
-29.26%457K
9.72%-1.05M
332.00%812K
-83.19%-654K
84.17%-1.22M
139.20%646K
-Change in payables and accrued expense
29.60%5.26M
12.48%5.3M
-119.27%-14.59M
53.23%12.43M
228.25%10.32M
-11.22%4.06M
-33.67%4.71M
0.73%-6.65M
-2.38%8.11M
-21.58%3.14M
-Change in other current assets
129.44%146K
159.47%713K
-83.38%108K
-136.54%-588K
19.63%457K
-273.43%-496K
-277.10%-1.2M
146.21%650K
114.25%1.61M
26.07%382K
-Change in other current liabilities
-419.26%-431K
-117.74%-182K
-267.65%-250K
240.13%852K
-391.84%-241K
218.42%135K
568.49%1.03M
69.91%-68K
46.10%-608K
90.00%-49K
Cash from discontinued investing activities
Operating cash flow
365.64%23.34M
733.86%24M
73.13%-6.84M
86.49%-5.63M
409.78%18.59M
195.94%5.01M
57.94%-3.79M
-18.71%-25.44M
-119.43%-41.66M
-115.75%-6M
Investing cash flow
Cash flow from continuing investing activities
-52.34%-14.79M
-39.19%-21.42M
-218.80%-19.7M
90.28%-16.18M
-71.17%-7.67M
92.76%-9.71M
44.07%-15.39M
4,225.37%16.58M
-149.85%-166.55M
85.49%-4.48M
Net PPE purchase and sale
-159.85%-6.37M
-29.64%-5.23M
-174.44%-9.15M
-150.29%-13.61M
-136.73%-3.79M
-20.42%-2.45M
-188.62%-4.03M
-729.10%-3.33M
-56.55%-5.44M
-80.09%-1.6M
Net business purchase and sale
----
----
----
--0
----
----
----
----
---26.97M
--0
Net investment purchase and sale
-15.99%-8.42M
-42.58%-16.19M
-152.99%-10.55M
98.09%-2.58M
-34.74%-3.88M
94.50%-7.26M
---11.36M
--19.92M
---134.69M
---2.88M
Net other investing changes
----
----
----
----
----
----
----
----
100.87%547K
--0
Cash from discontinued investing activities
Investing cash flow
-52.34%-14.79M
-39.19%-21.42M
-218.80%-19.7M
90.28%-16.18M
-71.17%-7.67M
92.76%-9.71M
44.07%-15.39M
4,225.37%16.58M
-149.85%-166.55M
85.49%-4.48M
Financing cash flow
Cash flow from continuing financing activities
1,762.22%838K
-81.42%42K
1,362.09%10.64M
-251.68%-2.3M
-339.60%-3.3M
-88.40%45K
-65.81%226K
-40.13%728K
-72.05%1.52M
-695.24%-750K
Net issuance payments of debt
33.33%-24K
68.57%-11K
28,568.57%9.96M
-16.39%-142K
-5.88%-36K
-9.09%-36K
-12.90%-35K
-45.83%-35K
-1,425.00%-122K
-325.00%-34K
Proceeds from stock option exercised by employees
512.50%2.16M
-15.97%668K
7.15%1.15M
-10.44%2.98M
-10.02%754K
-24.63%352K
9.81%795K
-16.90%1.08M
-49.21%3.33M
-8.42%838K
Net other financing activities
-377.49%-1.29M
-15.17%-615K
-50.96%-474K
-204.15%-5.13M
-158.37%-4.02M
-489.13%-271K
-1,568.75%-534K
-460.71%-314K
-51.12%-1.69M
-98.98%-1.55M
Cash from discontinued financing activities
Financing cash flow
1,762.22%838K
-81.42%42K
1,362.09%10.64M
-251.68%-2.3M
-339.60%-3.3M
-88.40%45K
-65.81%226K
-40.13%728K
-72.05%1.52M
-695.24%-750K
Net cash flow
Beginning cash position
-10.75%85.57M
-27.76%82.95M
-19.61%98.84M
-62.70%122.95M
-32.01%91.22M
-64.90%95.87M
-62.84%114.82M
-62.70%122.95M
-19.57%329.63M
-63.05%134.18M
Current changes in cash
301.83%9.39M
113.84%2.62M
-95.55%-15.89M
88.34%-24.11M
167.82%7.62M
96.65%-4.65M
47.15%-18.95M
60.58%-8.13M
-157.65%-206.69M
66.52%-11.23M
End cash Position
4.10%94.96M
-10.75%85.57M
-27.76%82.95M
-19.61%98.84M
-19.61%98.84M
-32.01%91.22M
-64.90%95.87M
-62.84%114.82M
-62.70%122.95M
-62.70%122.95M
Free cash flow
563.28%16.96M
339.98%18.77M
44.45%-15.99M
59.30%-19.25M
289.98%14.79M
135.21%2.56M
24.84%-7.82M
-31.81%-28.78M
-110.48%-47.29M
-111.95%-7.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 365.64%23.34M733.86%24M73.13%-6.84M86.49%-5.63M409.78%18.59M195.94%5.01M57.94%-3.79M-18.71%-25.44M-119.43%-41.66M-115.75%-6M
Net income from continuing operations 132.86%2.27M147.50%8.92M91.32%-2.53M14.41%-57.47M87.49%-2.58M65.90%-6.91M-1,039.38%-18.78M-18.60%-29.2M-114.55%-67.14M-220.65%-20.62M
Depreciation and amortization 11.56%3.54M10.13%3.35M15.49%3.34M16.95%12.33M13.48%3.22M8.59%3.17M15.68%3.04M34.45%2.89M209.45%10.54M95.80%2.84M
Deferred tax --5.25M---1.54M--088.12%-223K-521.05%-236K--0--0-89.43%13K78.51%-1.88M99.57%-38K
Other non cash items 76.06%125K-4,900.00%-96K-15.17%179K103.50%635K207.01%351K1,875.00%71K100.01%2K-91.80%211K---18.13M---328K
Change In working capital 127.69%776K1,149.67%1.91M-61.38%-18.8M-94,614.29%-6.63M125.21%7.67M-190.56%-2.8M-95.71%153K-15.61%-11.65M99.83%-7K-14.56%3.4M
-Change in receivables 26.67%-4.25M6.59%-3.36M2.76%-4.26M-140.11%-14.93M-113.15%-1.15M-11,502.00%-5.8M-23.84%-3.6M-60.84%-4.38M-34.27%-6.22M-137.09%-540K
-Change in inventory 309.38%1.44M77.01%-368K155.00%297K-135.83%-3.96M-1,120.79%-2.17M180.73%352K-117.23%-1.6M-64.13%-540K-613.76%-1.68M-150.14%-178K
-Change in prepaid assets -31.90%-1.39M-123.52%-191K84.25%-103K64.46%-435K-29.26%457K9.72%-1.05M332.00%812K-83.19%-654K84.17%-1.22M139.20%646K
-Change in payables and accrued expense 29.60%5.26M12.48%5.3M-119.27%-14.59M53.23%12.43M228.25%10.32M-11.22%4.06M-33.67%4.71M0.73%-6.65M-2.38%8.11M-21.58%3.14M
-Change in other current assets 129.44%146K159.47%713K-83.38%108K-136.54%-588K19.63%457K-273.43%-496K-277.10%-1.2M146.21%650K114.25%1.61M26.07%382K
-Change in other current liabilities -419.26%-431K-117.74%-182K-267.65%-250K240.13%852K-391.84%-241K218.42%135K568.49%1.03M69.91%-68K46.10%-608K90.00%-49K
Cash from discontinued investing activities
Operating cash flow 365.64%23.34M733.86%24M73.13%-6.84M86.49%-5.63M409.78%18.59M195.94%5.01M57.94%-3.79M-18.71%-25.44M-119.43%-41.66M-115.75%-6M
Investing cash flow
Cash flow from continuing investing activities -52.34%-14.79M-39.19%-21.42M-218.80%-19.7M90.28%-16.18M-71.17%-7.67M92.76%-9.71M44.07%-15.39M4,225.37%16.58M-149.85%-166.55M85.49%-4.48M
Net PPE purchase and sale -159.85%-6.37M-29.64%-5.23M-174.44%-9.15M-150.29%-13.61M-136.73%-3.79M-20.42%-2.45M-188.62%-4.03M-729.10%-3.33M-56.55%-5.44M-80.09%-1.6M
Net business purchase and sale --------------0-------------------26.97M--0
Net investment purchase and sale -15.99%-8.42M-42.58%-16.19M-152.99%-10.55M98.09%-2.58M-34.74%-3.88M94.50%-7.26M---11.36M--19.92M---134.69M---2.88M
Net other investing changes --------------------------------100.87%547K--0
Cash from discontinued investing activities
Investing cash flow -52.34%-14.79M-39.19%-21.42M-218.80%-19.7M90.28%-16.18M-71.17%-7.67M92.76%-9.71M44.07%-15.39M4,225.37%16.58M-149.85%-166.55M85.49%-4.48M
Financing cash flow
Cash flow from continuing financing activities 1,762.22%838K-81.42%42K1,362.09%10.64M-251.68%-2.3M-339.60%-3.3M-88.40%45K-65.81%226K-40.13%728K-72.05%1.52M-695.24%-750K
Net issuance payments of debt 33.33%-24K68.57%-11K28,568.57%9.96M-16.39%-142K-5.88%-36K-9.09%-36K-12.90%-35K-45.83%-35K-1,425.00%-122K-325.00%-34K
Proceeds from stock option exercised by employees 512.50%2.16M-15.97%668K7.15%1.15M-10.44%2.98M-10.02%754K-24.63%352K9.81%795K-16.90%1.08M-49.21%3.33M-8.42%838K
Net other financing activities -377.49%-1.29M-15.17%-615K-50.96%-474K-204.15%-5.13M-158.37%-4.02M-489.13%-271K-1,568.75%-534K-460.71%-314K-51.12%-1.69M-98.98%-1.55M
Cash from discontinued financing activities
Financing cash flow 1,762.22%838K-81.42%42K1,362.09%10.64M-251.68%-2.3M-339.60%-3.3M-88.40%45K-65.81%226K-40.13%728K-72.05%1.52M-695.24%-750K
Net cash flow
Beginning cash position -10.75%85.57M-27.76%82.95M-19.61%98.84M-62.70%122.95M-32.01%91.22M-64.90%95.87M-62.84%114.82M-62.70%122.95M-19.57%329.63M-63.05%134.18M
Current changes in cash 301.83%9.39M113.84%2.62M-95.55%-15.89M88.34%-24.11M167.82%7.62M96.65%-4.65M47.15%-18.95M60.58%-8.13M-157.65%-206.69M66.52%-11.23M
End cash Position 4.10%94.96M-10.75%85.57M-27.76%82.95M-19.61%98.84M-19.61%98.84M-32.01%91.22M-64.90%95.87M-62.84%114.82M-62.70%122.95M-62.70%122.95M
Free cash flow 563.28%16.96M339.98%18.77M44.45%-15.99M59.30%-19.25M289.98%14.79M135.21%2.56M24.84%-7.82M-31.81%-28.78M-110.48%-47.29M-111.95%-7.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data